Literature DB >> 14615632

An Automated Peak Identification/Calibration Procedure for High-Dimensional Protein Measures From Mass Spectrometers.

Yutaka Yasui, Dale McLerran, Bao-Ling Adam, Marcy Winget, Mark Thornquist, Ziding Feng.   

Abstract

Discovery of "signature" protein profiles that distinguish disease states (eg, malignant, benign, and normal) is a key step towards translating recent advancements in proteomic technologies into clinical utilities. Protein data generated from mass spectrometers are, however, large in size and have complex features due to complexities in both biological specimens and interfering biochemical/physical processes of the measurement procedure. Making sense out of such high-dimensional complex data is challenging and necessitates the use of a systematic data analytic strategy. We propose here a data processing strategy for two major issues in the analysis of such mass-spectrometry-generated proteomic data: (1) separation of protein "signals" from background "noise" in protein intensity measurements and (2) calibration of protein mass/charge measurements across samples. We illustrate the two issues and the utility of the proposed strategy using data from a prostate cancer biomarker discovery project as an example.

Entities:  

Year:  2003        PMID: 14615632      PMCID: PMC514270          DOI: 10.1155/S111072430320927X

Source DB:  PubMed          Journal:  J Biomed Biotechnol        ISSN: 1110-7243


  13 in total

Review 1.  Proteomics in early detection of cancer.

Authors:  P R Srinivas; S Srivastava; S Hanash; G L Wright
Journal:  Clin Chem       Date:  2001-10       Impact factor: 8.327

2.  Proteinchip(R) surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures.

Authors:  G L Wright; L H Cazares; S-M Leung; S Nasim; B-L Adam; T-T Yip; P F Schellhammer; L Gong; A Vlahou
Journal:  Prostate Cancer Prostatic Dis       Date:  1999-12       Impact factor: 5.554

3.  Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology.

Authors:  Christophe Rosty; Laurence Christa; Scott Kuzdzal; William M Baldwin; Marianna L Zahurak; Françoise Carnot; Daniel W Chan; Marcia Canto; Keith D Lillemoe; John L Cameron; Charles J Yeo; Ralph H Hruban; Michael Goggins
Journal:  Cancer Res       Date:  2002-03-15       Impact factor: 12.701

Review 4.  Proteomic approaches to biomarker discovery in prostate and bladder cancers.

Authors:  B L Adam; A Vlahou; O J Semmes; G L Wright
Journal:  Proteomics       Date:  2001-10       Impact factor: 3.984

5.  Use of proteomic patterns in serum to identify ovarian cancer.

Authors:  Emanuel F Petricoin; Ali M Ardekani; Ben A Hitt; Peter J Levine; Vincent A Fusaro; Seth M Steinberg; Gordon B Mills; Charles Simone; David A Fishman; Elise C Kohn; Lance A Liotta
Journal:  Lancet       Date:  2002-02-16       Impact factor: 79.321

6.  An integrated approach utilizing artificial neural networks and SELDI mass spectrometry for the classification of human tumours and rapid identification of potential biomarkers.

Authors:  G Ball; S Mian; F Holding; R O Allibone; J Lowe; S Ali; G Li; S McCardle; I O Ellis; C Creaser; R C Rees
Journal:  Bioinformatics       Date:  2002-03       Impact factor: 6.937

7.  Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients.

Authors:  Yinsheng Qu; Bao-Ling Adam; Yutaka Yasui; Michael D Ward; Lisa H Cazares; Paul F Schellhammer; Ziding Feng; O John Semmes; George L Wright
Journal:  Clin Chem       Date:  2002-10       Impact factor: 8.327

8.  Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.

Authors:  Bao-Ling Adam; Yinsheng Qu; John W Davis; Michael D Ward; Mary Ann Clements; Lisa H Cazares; O John Semmes; Paul F Schellhammer; Yutaka Yasui; Ziding Feng; George L Wright
Journal:  Cancer Res       Date:  2002-07-01       Impact factor: 12.701

9.  A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection.

Authors:  Yutaka Yasui; Margaret Pepe; Mary Lou Thompson; Bao-Ling Adam; George L Wright; Yinsheng Qu; John D Potter; Marcy Winget; Mark Thornquist; Ziding Feng
Journal:  Biostatistics       Date:  2003-07       Impact factor: 5.899

10.  Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer.

Authors:  C P Paweletz; B Trock; M Pennanen; T Tsangaris; C Magnant; L A Liotta; E F Petricoin
Journal:  Dis Markers       Date:  2001       Impact factor: 3.434

View more
  23 in total

1.  Formative evaluation of a prototype system for automated analysis of mass spectrometry data.

Authors:  N Fananapazir; M Li; D Spentzos; C F Aliferis
Journal:  AMIA Annu Symp Proc       Date:  2005

2.  Precision enhancement of MALDI-TOF MS using high resolution peak detection and label-free alignment.

Authors:  Maureen B Tracy; Haijian Chen; Dennis M Weaver; Dariya I Malyarenko; Maciek Sasinowski; Lisa H Cazares; Richard R Drake; O John Semmes; Eugene R Tracy; William E Cooke
Journal:  Proteomics       Date:  2008-04       Impact factor: 3.984

3.  A cautionary note on the evaluation of biomarkers of subtypes of a single disease.

Authors:  Adeniyi J Adewale; Qi Liu; Irina Dinu; Paul D Lampe; Bree L Mitchell; Yutaka Yasui
Journal:  Am J Epidemiol       Date:  2008-07-15       Impact factor: 4.897

4.  A novel comprehensive wave-form MS data processing method.

Authors:  Shuo Chen; Ming Li; Don Hong; Dean Billheimer; Huiming Li; Baogang J Xu; Yu Shyr
Journal:  Bioinformatics       Date:  2009-01-28       Impact factor: 6.937

Review 5.  Proteomics and the analysis of proteomic data: an overview of current protein-profiling technologies.

Authors:  Erol E Gulcicek; Christopher M Colangelo; Walter McMurray; Kathryn Stone; Kenneth Williams; Terence Wu; Hongyu Zhao; Heidi Spratt; Alexander Kurosky; Baolin Wu
Journal:  Curr Protoc Bioinformatics       Date:  2005-07

6.  Dermcidin expression is associated with disease progression and survival among breast cancer patients.

Authors:  Heather Ann Brauer; Monica D'Arcy; Tanya E Libby; Henry J Thompson; Yutaka Y Yasui; Nobuyuki Hamajima; Christopher I Li; Melissa A Troester; Paul D Lampe
Journal:  Breast Cancer Res Treat       Date:  2014-02-22       Impact factor: 4.872

7.  Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias.

Authors:  Dale McLerran; William E Grizzle; Ziding Feng; William L Bigbee; Lionel L Banez; Lisa H Cazares; Daniel W Chan; Jose Diaz; Elzbieta Izbicka; Jacob Kagan; David E Malehorn; Gunjan Malik; Denise Oelschlager; Alan Partin; Timothy Randolph; Nicole Rosenzweig; Shiv Srivastava; Sudhir Srivastava; Ian M Thompson; Mark Thornquist; Dean Troyer; Yutaka Yasui; Zhen Zhang; Liu Zhu; O John Semmes
Journal:  Clin Chem       Date:  2007-11-02       Impact factor: 8.327

8.  Computational Systems Bioinformatics and Bioimaging for Pathway Analysis and Drug Screening.

Authors:  Xiaobo Zhou; Stephen T C Wong
Journal:  Proc IEEE Inst Electr Electron Eng       Date:  2008-08-01       Impact factor: 10.961

9.  A unified modeling framework for metabonomic profile development and covariate selection for acute trauma subjects.

Authors:  S Ghosh; D K Dey
Journal:  Stat Med       Date:  2008-08-30       Impact factor: 2.373

10.  CSF proteomic fingerprints for HIV-associated cognitive impairment.

Authors:  Juliana Pérez Laspiur; Eric R Anderson; Pawel Ciborowski; Valerie Wojna; Wojciech Rozek; Fenghai Duan; Raul Mayo; Elaine Rodríguez; Marinés Plaud-Valentín; José Rodríguez-Orengo; Howard E Gendelman; Loyda M Meléndez
Journal:  J Neuroimmunol       Date:  2007-10-22       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.